The purpose of the National Cancer Institute pilot project to prioritize cancer antigens was to
develop a well-vetted, priority-ranked list of cancer vaccine target antigens based on …

Background Merkel-cell carcinoma is an aggressive skin cancer that is linked to exposure to
ultraviolet light and the Merkel-cell polyomavirus (MCPyV). Advanced Merkel-cell …

Sipuleucel-T (PROVENGE; Dendreon) is the first therapeutic cancer vaccine to be approved
by the US Food and Drug Administration. In men who have metastatic castration-resistant …

The HER-2/neu protooncogene is amplified and overexpressed in 20–40% of invasive breast
cancers. HER-2/neu protein overexpression is associated with aggressive disease and is …

Purpose: The HER-2/neu protein is a nonmutated tumor antigen that is overexpressed in a
variety of human malignancies, including breast and ovarian cancer. Many tumor antigens, …

One hundred ninety-eight patients with chronic myelogenous leukemia received marrow
transplants after intensive chemotherapy and total body irradiation. Multivariate analysis …

Purpose: To evaluate HER-2/neu-specific antibody immunity in patients with breast cancer,
to determine the rate of occurrence of serum antibodies to HER-2/neu in patients with breast …

HER-2/neu is a “self” tumor antigen that is overexpressed in 15–30% of human adenocarinomas.
Vaccine strategies directed against HER-2/neu and other self tumor antigens require …

PURPOSE Merkel cell carcinoma (MCC) is an aggressive skin cancer often caused by the
Merkel cell polyomavirus. Clinical trials of programmed cell death-1 pathway inhibitors for …

The current studies evaluate granulocyte-macrophage colony-stimulating factor (GM-CSF)
as a vaccine adjuvant. An important issue for developing vaccine therapy for human …